51. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible
- Author
-
Lwin, Thinzar M, Turner, Michael A, Amirfakhri, Siamak, Nishino, Hiroto, Hoffman, Robert M, and Bouvet, Michael
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Digestive Diseases ,Bioengineering ,Cancer ,Clinical Research ,Colo-Rectal Cancer ,Clinical Trials and Supportive Activities ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,Animals ,Biomarkers ,Tumor ,Colonic Neoplasms ,Fluorescence ,Fluorescent Dyes ,Humans ,Molecular Targeted Therapy ,tumor-specific antibodies ,fluorescent dyes ,tumor-specific labeling ,fluorescence-guided surgery ,Biological sciences ,Biomedical and clinical sciences - Abstract
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is the only curative modality. Fluorescence-enhanced visualization of CRC with targeted fluorescent probes that can delineate boundaries and target tumor-specific biomarkers can increase rates of curative resection. Approaches to enhancing visualization of the tumor-to-normal tissue interface are active areas of investigation. Nonspecific dyes are the most-used approach, but tumor-specific targeting agents are progressing in clinical trials. The present narrative review describes the principles of fluorescence targeting of CRC for diagnosis and fluorescence-guided surgery with molecular biomarkers for preclinical or clinical evaluation.
- Published
- 2022